News
Join our newsletter
Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update.
Press Release: EpiVax Announces Licensing of Immunogenicity Screening Toolkit, ISPRI, to AbCellera
PROVIDENCE, RI, June 8, 2020 /PRNewswire/ --...
Press Release: Intravacc and EpiVax team up in development of COVID-19 emerging vaccine
Bilthoven, The Netherlands, Providence, R.I.,...
Press Release: Pacific GeneTech Partners With EpiVax on a Novel Vaccine Approach for ASF
HONG KONG, May 1, 2020 (Newswire.com) - Pacific...
Press Release: Entos Pharmaceuticals partners with EpiVax to develop a pan-coronavirus DNA vaccine
EDMONTON, Alberta, April 28, 2020 -- Entos...
Press Release: PharmaJet partners with Immunomic Therapeutics and EpiVax to develop and deliver COVID-19 Vaccine
Originally published via PR Newswire GOLDEN,...
Press Release: Immunomic Therapeutics Forms Collaboration with EpiVax and PharmaJet to Develop Novel Vaccine Candidate Against COVID-19 Using its Investigational UNITE Platform
Read the original BusinessWire publication here....
Press Release: EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countries
PROVIDENCE, RI, April 7, 2020 /PRNewswire/ --...
Providence biotech firm is working on a coronavirus vaccine – Boston Globe interview
With 22 years of experience, EpiVax is in the...
Press Release: EpiVax Oncology Inc. Announces It Has Reduced the Timeline of Its Personalized Neoantigen Therapeutic Cancer Vaccine Process to Under Four Weeks
March 26, 2020 04:42 PM Eastern Daylight Time...
Press Release: eTheRNA launches an international consortium and starts development of cross-strain protective CoV-2 mRNA vaccine for high risk populations
March 24, 2020 Niel, Belgium: eTheRNA...
Providence-based EpiVax developing 2 coronavirus vaccines, needs more funding – WPRI News Channel 12 interview
Providence-based EpiVax developing 2 coronavirus...
Providence biotech company working to create coronavirus vaccine – Providence NBC 10 News interview
Providence biotech company working to create...